<DOC>
	<DOCNO>NCT01082627</DOCNO>
	<brief_summary>Primary Objective : To demonstrate whether early fix Somatostatin treatment improve complete recovery rate early postoperative simple small bowel obstruction ( EPSSBO ) compare common daily practice Notes : 1. complete recovery= toleration solid food+ flatus+ passage+ recovery bowel movement . 2. common daily practice include : - NPO ( Nil per mouth ) , re-dehydration , TPN ( Total Parenteral Nutrition ) need . Check &amp; make sure stability electrolytes daily . - GI ( Gastro-Intestinal ) depression via NGT ( Naso-Gastric Tube ) - Discontinue opiate , instead NSAIDs . ( Non-Steroidal Anti-Inflammatory Drugs ) - Pro-dynamic drug drug may interfere GI ( Gastro-Intestinal ) movement eg . anti-histamines , anti-cholinergic , opiate , anti-depressives indicate . Secondary Objectives : To investigate whether early fix Somatostatin treatment bring much benefit EPSSBO pt compare common daily practice , purpose , study investigate endpoint .</brief_summary>
	<brief_title>Identifying Effect Somatostatin Treatment Early Postoperative Simple Small Bowel Obstruction</brief_title>
	<detailed_description>1 . Study Design : This multi-centers , open label , randomize study , enroll 80 EPSSBO patient , assign two group randomly . All inclusive patient consistent diagnosis EPSSBO , mechanic SBO strangulate SBO rule advance . The inclusive patient assign two group follow ( ratio 3:1 ) - Arm A : Somatostatin+common daily practice ( 60 ) . - Arm B : common daily practice ( 20 ) . 2 . Total number subjects:80 EPSSBO patient . 3 . Schedule visit assessment , The following assessment perform . - Pre-screening : informed consent , demographic data , EPSSBO diagnosis . - Screening - Daily visit : - Weekly visit： - End study visit： 4 . Statistical method - As pilot study , formal statistical calculation carry sample size estimate 80 EPSSBO subject 3:1 ratio active control subject i.e . 60 Stilamin+ common daily practice 20 common daily practice . - The primary endpoint complete recovery rate estimate treatment group , 95 % confidence interval . The difference proportion treatment group also estimate treatment comparison perform use chi-square test . All statistical test 2-tailed significance level 0.05 . - Descriptive statistic include number ( N ) , mean , median , standard deviation , minimum maximum , produce continuous variable . Frequency table number ( N ) percentage subject produce categorical variable . - Continuous variable analyze use analysis variance ( ANOVA ) model effect treatment . The data check normality . If distribution normal , parametric technique use . If data normally distribute , non parametric technique use . These assumption also apply primary endpoint i.e . use non-parametric test necessary . All statistical test 2-tailed significance level 0.05 .</detailed_description>
	<mesh_term>Intestinal Obstruction</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Patient give write informed consent studyrelated activity carry . Males female , age 1870 . Recent open abdominal surgery history . Having follow symptom sign 5 day index operation : abdominal distention + inability pas flatus + inability passage + weak absent bowel sound . Xray : paucity bowel gas,01 airfluid level . CT : intestinal wall edema/thickness , mechanic obstruction After laparoscopic surgery . Recent drug history antihistamine , anticholinergic , antidepressives , postoperative usage opiate . Any : severe abdominal pain , colic , peritoneal sign , higpitched bowel sound , T &gt; 38℃ , tachycardia , bradycardia , WBC &gt; 12000/ul , Xray≥2 airfluid level , CT : mechanic obstruction . Any : Abdominopelvic abscess , Anastomotic leak , Appendicitis , Cholecystitis , Hemoperitoneum retroperitoneal hemorrhage , Hypokalemia , Hypomagnesemia , Pancreatitis , Sepsis.Uremia . Severe heart failure（NYHA III above） . History arrhythmia syncope . ECG QTc &gt; 0.44s . Severe renal function insufficiency （Calculated Creatinine Clearance Rate ( Ccr ) ＜30ml/min） . Severe Liver function insufficiency（CHILD B~C） . Hyper hypothyroidism intracranial GHsecreting tumor . Brittle DM . Pregnancy . Allergy ingredient Stilamin . History significant neurologic psychiatric disorder include dementia , seizure , bipolar disorder . Medical psychological condition would permit patient complete study sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Somatostatin small bowel obstruction</keyword>
</DOC>